Nine Masts Capital LTD Amgen Inc Transaction History

Nine Masts Capital LTD

  • $339 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 14, 2018
SELL
$169.43 - $198.0 $1.54 Million - $1.8 Million
-9,098 Closed
0 $0
Q4 2017

Feb 12, 2018
BUY
$168.79 - $188.59 $986,746 - $1.1 Million
5,846 Added 179.77%
9,098 $1.58 Million
Q3 2017

Nov 13, 2017
BUY
$167.29 - $191.0 $544,027 - $621,132
3,252
3,252 $606,000

Others Institutions Holding AMGN

# of Institutions
3,119
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Nine Masts Capital LTD Portfolio

Follow Nine Masts Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nine Masts Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nine Masts Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email